Monday, 12 March 2012

Statins in the dock

The FDA has updated statin labelling and literature to include prior screening for hepatic function. Also included in the release is the information that statins are implicated in a higher incidence( 8-13%) of diabetes in patients on them, especially with higher doses. Also highlighted is the connection, though tenous, between statin therapy and cognitive disorders.

The full article is here


John Vella B.Pharm. (Hons.) M.Sc.(Pharmacoeconomics)

8, Islets Promenade, Bugibba, SPB2502, Malta

+356-21571649, +356-27571649, +356-99497510

No comments:

Post a Comment